Logo image of RARE

ULTRAGENYX PHARMACEUTICAL IN (RARE) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RARE - US90400D1081 - Common Stock

23 USD
+0.22 (+0.97%)
Last: 12/31/2025, 8:25:45 PM
22.93 USD
-0.07 (-0.3%)
After Hours: 12/31/2025, 8:25:45 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RARE revenue by date.RARE revenue by date.
363.3M
3.39%
434.249M
19.53%
560.23M
29.01%
667.17M
19.09%
804.71M
20.62%
1.207B
49.99%
1.575B
30.49%
2.219B
40.89%
2.713B
22.26%
2.908B
7.19%
3.364B
15.68%
EBITDA
YoY % growth
RARE ebitda by date.RARE ebitda by date.
-630.68M
-71.17%
-543.202M
13.87%
-500.43M
7.87%
-510.406M
-1.99%
-377.26M
26.09%
-111.761M
70.38%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
RARE ebit by date.RARE ebit by date.
-648.9M
-70.00%
-569.208M
12.28%
-535.973M
5.84%
-532.324M
0.68%
-414.396M
22.15%
-158.148M
61.84%
241.53M
252.72%
750.81M
210.86%
1.107B
47.44%
1.333B
20.42%
1.679B
25.96%
Operating Margin
RARE operating margin by date.RARE operating margin by date.
-178.61%-131.08%-95.67%-79.79%-51.50%-13.10%15.34%33.84%40.80%45.84%49.91%
EPS
YoY % growth
RARE eps by date.RARE eps by date.
-10.11
-50.67%
-8.33
17.61%
-6.34
23.89%
-5.87
7.44%
-4.19
28.54%
-1.64
61.00%
1.68
202.66%
6.21
269.87%
10.72
72.67%
11.91
11.09%
15.34
28.77%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.19
14.14%
-1.64
-4.75%
-1.21
-3.28%
-1.16
36.10%
-0.73
39.00%
-0.94
42.94%
-0.23
80.59%
0.06
105.29%
0.67
192.48%
Revenue
Q2Q % growth
191.52M
16.16%
175.79M
26.20%
190.18M
14.22%
201.01M
25.68%
234.81M
22.60%
213.48M
21.44%
278.32M
46.35%
311.54M
54.99%
389.47M
65.87%
EBITDA
Q2Q % growth
-112.022M
-29.15%
-115.645M
13.67%
-109.543M
-21.34%
-105.839M
26.84%
-101.325M
9.55%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-113.121M
7.49%
-128.423M
10.16%
-116.284M
-7.78%
-112.412M
34.22%
-95.236M
15.81%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.81
-29.29%
-1.26-0.55-43.75%
Q2 2025
Q2Q % growth
-1.17
23.03%
-1.320.1511.68%
Q1 2025
Q2Q % growth
-1.57
22.66%
-1.650.084.60%
Q4 2024
Q2Q % growth
-1.39
8.55%
-1.32-0.07-5.63%
Q3 2024
Q2Q % growth
-1.40
37.22%
-1.480.085.37%
Q2 2024
Q2Q % growth
-1.52
32.44%
-1.730.2112.01%
Q1 2024
Q2Q % growth
-2.03
12.88%
-1.77-0.26-14.94%
Q4 2023
Q2Q % growth
-1.52
29.63%
-1.650.137.99%
Q3 2023
Q2Q % growth
-2.23
36.29%
-2.12-0.11-5.20%
Q2 2023
Q2Q % growth
-2.25
0.44%
-2.12-0.13-6.35%
Q1 2023
Q2Q % growth
-2.33
-6.39%
-2.02-0.31-15.58%
Q4 2022
Q2Q % growth
-2.16
-20.67%
-2.180.021.14%
Q3 2022
Q2Q % growth
-3.50
-224.07%
-1.85-1.65-89.21%
Q2 2022
Q2Q % growth
-2.26
-24.86%
-1.79-0.47-26.47%
Q1 2022
Q2Q % growth
-2.19
-7.88%
-1.80-0.39-21.97%
Q4 2021
Q2Q % growth
-1.79
-383.78%
-1.37-0.42-30.74%
Q3 2021
Q2Q % growth
-1.08
4.42%
-1.440.3624.80%
Q2 2021
Q2Q % growth
-1.81
-541.46%
-1.36-0.45-33.07%
Q1 2021
Q2Q % growth
-2.03
-6.28%
-1.26-0.77-60.89%
Q4 2020
Q2Q % growth
-0.37 -1.180.8168.76%
Q3 2020
Q2Q % growth
-1.13 -1.280.1511.98%
Q2 2020
Q2Q % growth
0.41 -1.571.98126.03%
Q1 2020
Q2Q % growth
-1.91 -1.72-0.19-11.34%
RARE Yearly EPS VS EstimatesRARE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 10 -10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
159.933M
14.65%
170.04M-10.107M-5.94%
Q2 2025
Q2Q % growth
166.496M
13.24%
164.82M1.676M1.02%
Q1 2025
Q2Q % growth
139.292M
27.99%
146.7M-7.408M-5.05%
Q4 2024
Q2Q % growth
164.877M
29.42%
158.5M6.377M4.02%
Q3 2024
Q2Q % growth
139.494M
42.27%
138.51M984K0.71%
Q2 2024
Q2Q % growth
147.026M
35.75%
125.64M21.386M17.02%
Q1 2024
Q2Q % growth
108.833M
8.30%
118.33M-9.497M-8.03%
Q4 2023
Q2Q % growth
127.392M
23.32%
121.77M5.622M4.62%
Q3 2023
Q2Q % growth
98.052M
8.11%
111.82M-13.768M-12.31%
Q2 2023
Q2Q % growth
108.309M
21.29%
106.9M1.409M1.32%
Q1 2023
Q2Q % growth
100.496M
25.78%
106.78M-6.284M-5.88%
Q4 2022
Q2Q % growth
103.3M
23.86%
107.22M-3.92M-3.66%
Q3 2022
Q2Q % growth
90.7M
11.15%
98.121M-7.421M-7.56%
Q2 2022
Q2Q % growth
89.3M
2.64%
89.265M35K0.04%
Q1 2022
Q2Q % growth
79.9M
-19.62%
85.327M-5.427M-6.36%
Q4 2021
Q2Q % growth
83.4M
-8.85%
85.471M-2.071M-2.42%
Q3 2021
Q2Q % growth
81.6M
0.12%
83.178M-1.578M-1.90%
Q2 2021
Q2Q % growth
87M
41.00%
87.6M-600K-0.68%
Q1 2021
Q2Q % growth
99.4M
173.83%
78.58M20.82M26.50%
Q4 2020
Q2Q % growth
91.5M 71.955M19.545M27.16%
Q3 2020
Q2Q % growth
81.5M 56.107M25.393M45.26%
Q2 2020
Q2Q % growth
61.7M 39.901M21.799M54.63%
Q1 2020
Q2Q % growth
36.3M 37.477M-1.177M-3.14%
RARE Yearly Revenue VS EstimatesRARE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.33% -1.55% -13.99% -14.16%
Revenue0% 2% -0.47% -0.52%